
(MedPage Today) — The recombinant herpes zoster vaccine (Shingrix) was not only associated with a reduced risk of herpes zoster ophthalmicus (HZO), but also lower risks of hospitalization for acute myocardial infarction (MI) and stroke, according…
Source link : https://www.medpagetoday.com/infectiousdisease/vaccines/117041
Author :
Publish date : 2025-08-18 18:09:00
Copyright for syndicated content belongs to the linked
Source.